Dulaglutide × HbA1c

Study 1 · Limited

GLP-1 agonists reduce heart fat thickness in diabetes.

Comparison

Patients received semaglutide as part of their treatment regimen. · Patients received dulaglutide as part of their treatment regimen. · Patients received metformin as the control treatment.

Duration / follow-up

12 weeks

Study 2 · Limited

Higher dulaglutide doses improve weight loss in type 2 diabetes

Rct

Comparison

Patients received once weekly dulaglutide 1.5 mg for 52 weeks. · Patients received once weekly dulaglutide 3.0 mg for 52 weeks. · Patients received once weekly dulaglutide 4.5 mg for 52 weeks.

Duration / follow-up

52 weeks

Study 3 · Included

Switching to tirzepatide improves glycemic control and weight in type 2 diabetes

Rct

Comparison

Participants continued with and escalated to dulaglutide. · Participants switched to tirzepatide with escalation.

Duration / follow-up

40 weeks